Follow Us On


May 22, 2023
Patients who took the diet drug Wegovy for a year had a reduced risk of heart disease in an early hint that Novo Nordisk’s best-selling obesity medicine may also have a positive impact on cardiovascular health. People followed in a study saw their 10-year risk of cardiovascular disease decline by 18%, said Andres Acosta, an associate...
Read More